These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 24612897)

  • 21. Parvovirus B19 infection in pregnancy.
    Crane J; Mundle W; Boucoiran I;
    J Obstet Gynaecol Can; 2014 Dec; 36(12):1107-1116. PubMed ID: 25668048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preventing infective sequelae of abortion.
    Penney GC
    Hum Reprod; 1997 Nov; 12(11 Suppl):107-12. PubMed ID: 9433966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of intrauterine contraceptive devices, pelvic inflammatory disease, and Chlamydia trachomatis infection.
    Edelman DA
    Am J Obstet Gynecol; 1988 Apr; 158(4):956-9. PubMed ID: 3284365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrauterine Devices in the Context of Gonococcal Infection, Chlamydial Infection, and Pelvic Inflammatory Disease: Not Mutually Exclusive.
    Esposito CP
    J Midwifery Womens Health; 2020 Jul; 65(4):562-566. PubMed ID: 32592523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pregnancy outcomes after assisted human reproduction.
    Okun N; Sierra S; ;
    J Obstet Gynaecol Can; 2014 Jan; 36(1):64-83. PubMed ID: 24444289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylactic antibiotics for intrauterine device insertion: a metaanalysis of the randomized controlled trials.
    Grimes DA; Schulz KF
    Contraception; 1999 Aug; 60(2):57-63. PubMed ID: 10592851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The management of uterine fibroids in women with otherwise unexplained infertility.
    Carranza-Mamane B; Havelock J; Hemmings R; ;
    J Obstet Gynaecol Can; 2015 Mar; 37(3):277-285. PubMed ID: 26001875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The safety of intrauterine contraception initiation among women with current asymptomatic cervical infections or at increased risk of sexually transmitted infections.
    Jatlaoui TC; Simmons KB; Curtis KM
    Contraception; 2016 Dec; 94(6):701-712. PubMed ID: 27263041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of sexually transmitted disease risk assessment algorithms for selection of intrauterine device candidates.
    Morrison CS; Sekadde-Kigondu C; Miller WC; Weiner DH; Sinei SK
    Contraception; 1999 Feb; 59(2):97-106. PubMed ID: 10361624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Contraception and pelvic infection in women].
    Keith L; Berger GS; Brown ER
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):49-58. PubMed ID: 12341241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic prophylaxis for intrauterine contraceptive device insertion.
    Grimes DA; Schulz KF
    Cochrane Database Syst Rev; 2001; (1):CD001327. PubMed ID: 11279714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cervical insufficiency and cervical cerclage.
    Brown R; Gagnon R; Delisle MF;
    J Obstet Gynaecol Can; 2013 Dec; 35(12):1115-1127. PubMed ID: 24405880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrauterine contraceptive devices and risk of pelvic inflammatory disease: standard of care in high STI prevalence settings.
    Steen R; Shapiro K
    Reprod Health Matters; 2004 May; 12(23):136-43. PubMed ID: 15242222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IUD users in Norway are at low risk for genital C. trachomatis infection.
    Skjeldestad FE; Halvorsen LE; Kahn H; Nordbø SA; Saake K
    Contraception; 1996 Oct; 54(4):209-12. PubMed ID: 8922873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The etiology of pelvic inflammatory disease.
    Keith L; Berger GS
    Res Front Fertil Regul; 1984 May; 3(1):1-16. PubMed ID: 12179634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute pelvic inflammatory disease.
    Eschenbach DA
    Urol Clin North Am; 1984 Feb; 11(1):65-81. PubMed ID: 6369707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk-based screening for Chlamydia trachomatis and Neisseria gonorrhoeae prior to intrauterine device insertion.
    Grentzer JM; Peipert JF; Zhao Q; McNicholas C; Secura GM; Madden T
    Contraception; 2015 Oct; 92(4):313-8. PubMed ID: 26093189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low risk of infection from IUD use shown.
    Contracept Technol Update; 1998 Aug; 19(8):102-3. PubMed ID: 12348575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibiotic prophylaxis for intrauterine contraceptive device insertion.
    Grimes DA; Schulz KF
    Cochrane Database Syst Rev; 2000; 1999(2):CD001327. PubMed ID: 10796777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preventing IUCD-related pelvic infection: the efficacy of prophylactic doxycycline at insertion.
    Sinei SK; Schulz KF; Lamptey PR; Grimes DA; Mati JK; Rosenthal SM; Rosenberg MJ; Riara G; Njage PN; Bhullar VB
    Br J Obstet Gynaecol; 1990 May; 97(5):412-9. PubMed ID: 2196934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.